首页> 外文期刊>Chest: The Journal of Circulation, Respiration and Related Systems >Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis.
【24h】

Catheter-directed embolectomy, fragmentation, and thrombolysis for the treatment of massive pulmonary embolism after failure of systemic thrombolysis.

机译:全身性溶栓失败后,进行导管定向栓塞切除术,破碎和溶栓治疗大量肺栓塞。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSES: The standard medical management for patients in extremis from massive pulmonary embolism (PE) is systemic thrombolysis, but the utility of this treatment relative to catheter-directed intervention (CDI) is unknown. We evaluated the effectiveness of CDI as part of a treatment algorithm for life-threatening PE. METHODS: A retrospective review was performed on 70 consecutive patients with suspected acute PE over a 10-year period (from 1997 to 2006) who had been referred for pulmonary angiography and/or intervention. The criteria for study inclusion were patients who received CDI due to angiographically confirmed massive PE and hemodynamic shock (shock index, > or = 0.9). CDI involved suction embolectomy and fragmentation with or without catheter thrombolysis. RESULTS: Twelve patients were treated with CDI. There were seven men and five women (mean age, 56 years; age range, 21 to 80 years). Seven patients (58%) were referred for CDI after failing systemic infusion with 100 mg of tissue plasminogen activator, and five patients (42%) had contraindications to systemic thrombolysis. Catheter-directed fragmentation and embolectomy were performed in all patients (100%). Additionally, catheter-guided thrombolysis was performed in eight patients (67%). Technical success was achieved in 12 of 12 cases (100%). There were no major procedural complications (0%). Significant hemodynamic improvement (shock index, < 0.9) was observed in 10 of 12 cases (83%). The remaining two patients (17%) died secondary to cardiac arrest within 24 h. Ten of 12 patients (83%) survived and remained stable until hospital discharge (mean duration, 20 days; range, 3 to 51 days). CONCLUSION: In the setting of hemodynamic shock from massive PE, CDI is potentially a life-saving treatment for patients who have not responded to or cannot tolerate systemic thrombolysis.
机译:目的:发生大面积肺栓塞(PE)的极端患者的标准医疗管理是全身溶栓,但相对于导管直接干预(CDI)而言,这种治疗的效用尚不清楚。我们评估了CDI作为威胁生命的PE的治疗算法的一部分的有效性。方法:回顾性分析了10年来(1997年至2006年)连续70例疑似急性PE的患者,这些患者被转诊接受肺血管造影和/或介入治疗。纳入研究的标准是由于血管造影证实的大量PE和血流动力学休克(休克指数,≥0.9)而接受CDI的患者。 CDI涉及抽吸栓子切除术,并伴或不伴导管溶栓而破裂。结果:12例患者接受了CDI治疗。男7例,女5例(平均年龄56岁;年龄范围21至80岁)。全身输注100 mg组织纤溶酶原激活剂失败后,有7名患者(58%)被转诊为CDI,五名患者(42%)出现全身性溶栓的禁忌症。所有患者(100%)均进行了导管定向破碎术和栓子切除术。此外,在八名患者(67%)中进行了导管引导的溶栓治疗。 12例病例中有12例取得了技术成功(100%)。没有重大的手术并发症(0%)。 12例患者中有10例(83%)的血流动力学显着改善(休克指数,<0.9)。其余两名患者(17%)在24小时内死于心脏骤停。 12名患者中有10名(83%)存活并保持稳定,直到出院为止(平均持续时间20天;范围3至51天)。结论:在发生大面积PE引起的血流动力学休克的情况下,对于那些对全身溶栓没有反应或不能耐受的患者,CDI可能是一种挽救生命的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号